2022-02-22

Modern Healthcare: How is extended genotyping shaping the future of cervical cancer screening?

Modern Healthcare: How is extended genotyping shaping the future of cervical cancer screening?

In this op-ed, Dr. Jeff Andrews, Vice President of Medical Affairs for Integrated Diagnostic Solutions at BD, board-certified obstetrician and gynecologist, former chief medical research advisor for the American Society for Colposcopy and Cervical Pathology, and former professor at Duke University Medical Center and at Vanderbilt University Medical Center, shares his vision.

Latest resources

Discover our latest articles, webinars, press releases and updates in women's health.

BD Onclarity™ HPV Assay with extended genotyping
Cervical Cancer | Brochures
BD Onclarity™ HPV Assay with extended genotyping
Chris Beddard, Vice President, U.S. Marketing, Integrated Diagnostic Solutions at BD
Cervical Cancer | News & Updates
NJBIZ Conversations: Chris Beddard
Original research: Performance of a vaginal panel assay compared with the clinical diagnosis of vaginitis
Original research: Performance of a vaginal panel assay compared with the clinical diagnosis of vaginitis